Food and Drug Administration, et al., Applicants v. Alliance For Hippocratic Medicine, et al.

  1. June 22, 2023

    Abortion Litigation To Watch As Dobbs Decision Turns 1

    The U.S. Supreme Court's elimination of the constitutional right to abortion hit like an earthquake last summer, uprooting long-standing reproductive rights, triggering state laws curbing abortion access and flooding courts with litigation. A year later, legal battles promise further shake-ups to the abortion landscape.

  2. April 21, 2023

    Supreme Court Preserves Abortion Pill Access, For Now

    The U.S. Supreme Court preserved access to a widely used abortion medication Friday evening, putting the brakes on a Texas federal judge's ruling that would have undone the U.S. Food and Drug Administration's decades-old approval of the drug.

  3. April 18, 2023

    Abortion Pill Foes Tell Justices FDA 'Federalized Abortion'

    Anti-abortion groups and physicians asked the U.S. Supreme Court on Tuesday to preserve lower court decisions halting FDA approvals of a common abortion medication, arguing the agency flouted numerous laws, removed safeguards protecting women's health and "effectively federalized abortion" by allowing the drug to be mailed to states prohibiting it.

  4. April 17, 2023

    Ex-FDA Officials, Legal Scholars Rip Abortion Pill Ruling

    Former U.S. Food and Drug Administration officials who served under Republican and Democratic administrations urged the U.S. Supreme Court to reverse a Texas federal judge's order invalidating the agency's approval of a widely used abortion medication, saying "judicial second-guessing of FDA's safety determinations would have serious negative consequences for the public health."

  5. April 14, 2023

    Justice Alito Keeps US Access To Abortion Pill, For Now

    U.S. Supreme Court Justice Samuel Alito on Friday issued a five-day stay on a Texas federal judge's injunction that would have blocked distribution of a widely used abortion medication, after the U.S. Department of Justice and the drugmaker Danco Laboratories said they were in "untenable limbo" of competing court orders and facing "regulatory chaos."